Treatment and Survival Disparities in Asian Americans With Hepatocellular Carcinoma
AANHPI with early-stage HCC had better survival as a cohort. However, when disaggregated, there were notable disparities among different subgroups. AANHPI represents an incredibly diverse group of individuals, and it is imperative for physicians, researchers, and policy makers to appreciate the true heterogeneity of this population.
Authors
- Nicole Ng (ORCID: https://orcid.org/0000-0001-9488-6970)
- Xiaohan Ying (ORCID: https://orcid.org/0000-0001-5586-4314)
- Russell Rosenblatt
- Catherine Lucero (ORCID: https://orcid.org/0000-0003-1897-0075)
- Arun Jesudian (ORCID: https://orcid.org/0000-0002-8562-3375)
- Peter T. Silberstein (ORCID: https://orcid.org/0000-0003-1207-0287)
- Ricki Lieu (ORCID: https://orcid.org/0000-0001-7813-1068)
- Robert Hu
Institutions
- Creighton University (US)
- Cornell University (US)
- Weill Cornell Medicine (US)
Publication Details
- Journal
- Journal of Clinical Gastroenterology
- Published
- 2024-10-14
- DOI
- https://doi.org/10.1097/mcg.0000000000002076
- Citations
- 2
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.74